Project Examples
We provide deliverables that drive decision making and business outcomes for emerging life science companies in three core areas:

MARKET STRATEGY
Competitive landscape and mapping
Target and competitive product profile
Treatment process
Patient metric driven forecasting
Secondary market analysis
Oversee primary market research
KOL interviews

LICENSING AND BUSINESS DEVELOPMENT
Representation on an hourly or project basis
Deal valuation, comparables analysis
Strategic partner recommendations

STRATEGIC ANALYSIS
Research portfolio review and trade-off analysis
Clinical indication prioritization
Defining corporate focus
Services
  • Commercialization plan for anti-infective diagnostic
  • Competitive landscape for melanoma treatment
  • Target product profile and positioning for myeloma product
  • Partnering representation for antibody library generation platform
  • Licensing representation for Phase 1 antibody product for oncology indcations
  • KOL interviews to assess in-licensing decision in oncology
  • Assessment of immunology licensing opportunity
  • Business path strategic analysis -new biologics business

email me
carolyn@siegalconsulting.com
AEMF
LARTA
STRATINOVA
IMMURX
TRANSMEMBRANE BIO
PROTEOLIX
ABRAXIS BIOSCIENCE
SPECTRUM
XOMA
XENCOR
NOVARTIS
NISSAN CHEMICAL
CHIOME BIOSCIENCE
AMI@USC
NEREUS
KINETICHEM
ACODAVISION
MOLECULAR EXPRESS
ARIGEN

Clients